The effect of wattle tannin drenches on gastrointestinal nematodes of tropical sheep and goats during experimental and natural infections

2009 ◽  
Vol 147 (2) ◽  
pp. 211-218 ◽  
Author(s):  
R. A. MAX ◽  
A. A. KASSUKU ◽  
A. E. KIMAMBO ◽  
L. A. MTENGA ◽  
D. WAKELIN ◽  
...  

SUMMARYIn previous work, administration of a commercial tannin preparation, quebracho, as oral drench was shown to reduce significantly faecal egg counts (FEC) and worm burdens of temperate sheep with experimental Haemonchus contortus infection. In the current work carried out in Morogoro, Tanzania, three separate animal trials were carried out to investigate the effect of drenches of wattle tannin (WT), a similar tannin preparation that is readily available in the tropics, on nematodes of tropical goats and sheep. In the first trial, 36 young Small East African (SEA) goats were experimentally infected with a single dose of mixed nematode larvae and FEC were monitored regularly. On day 30 post-infection (p.i.), the animals were blocked on the basis of their FEC and randomly assigned into three equal groups (n=12). For 3 consecutive days, two groups received low and high doses of drench at a rate of 1·2 and 2·4 g WT/kg bodyweight, respectively, whereas the third group received a placebo drench (i.e. water). All goats were humanely slaughtered on day 42 p.i. and their worm burdens were assessed. Neither FEC nor worm burdens were significantly reduced by the administration of the low or high dose of WT. The second trial had an identical design but two groups (n=14) of growing Black Head Persian (BHP) sheep were used instead. One group received the drench at 1·5 g WT/kg body wt for 3 consecutive days, whereas the other group received a placebo. Unlike in goats, worm burdens and FEC were significantly reduced (P<0·001) by the drench administration. In the third trial, the effect of WT drench against a naturally acquired nematode infestation in a flock of 34 BHP sheep was determined. FEC were examined three times in a 2-week period and the egg counts were used to block the sheep before being randomly assigned into two groups (n=17). The treated group received the drench at 1·0 g WT/kg bodyweight for 3 consecutive days, while the remaining half was given a placebo. The two groups continued to graze together as FEC were being monitored. Results indicated a significant (P<0·001) reduction in egg counts, which remained low for at least 3 weeks after the drench. The current study demonstrated that the WT drench had significant anthelmintic activity against important nematodes in sheep but not in goats, suggesting an existence of species differences between the two hosts. It was concluded that WT drenches could be used in combination with other worm control strategies to reduce or control nematode infections, at least in sheep.

2019 ◽  
Author(s):  
Anteneh Wondimu ◽  
Yehualashet Bayu

Abstract Background: The occurrence of anthelmintic resistance to commonly used drugs is becoming worldwide constrain in livestock production. Considering the narrow range of available drugs and slow rate of new drug development, anthelmintic resistance presents an alarming global threat demanding vigilant monitoring and management. It is likely that anthelmintic resistance of gastrointestinal goats present in Ethiopia, but little information regarding the prevalence and species of nematode resistance to drugs is available. Current study done with objective to assess anthelmintic resistance of gastrointestinal nematodes of goats to commonly used anthelmintic drugs. Results: The result of the FECRT % and lower 95% confidence limit reported the presence of anthelmintic resistance for tested drugs; albendazole (41.5%, 36.9), tetraclozan (69.5%, 66.1), tetramisole (91.1%, 87.4) and ivermectin (43%, 38.2) respectively. Trichostrongylus spp, Teladorsagia spp and Haemonchus spp showed anthelmintic resistance for all tested drugs. Coproculture from different treated group revealed of Trichostrongylus spp (69.2% in ivermectin and 59.6% in albendazole) was the predominant nematode followed by Teladorsagia spp (21.9% in albendazole and 14.7% in ivermectin). In tetraclozan treatment group, Trichostrongylus spp (42%) and Teladorsagia spp (41.3%) were comparable, followed by Haemonchus spp (13%). In group treated with tetramisole, Teladorsagia spp (54.3%) was the major nematode detected followed by Trichostrongylus spp (25.7%) and Haemonchus spp (11.4%). Conclusions: The study demonstrated the presence of multi-drug resistant nematodes mainly Trichostrongylus spp, Teladorsagia spp and Haemonchus spp. Control strategies including management practices of pasture rotation, supplementary feeding and encouraging traditional nematode control methods. Further studies covering wider areas of Ethiopia and mechanism of nematode resistance need to be studied in future.


1975 ◽  
Vol 3 (4) ◽  
pp. 245-250
Author(s):  
Mam Chandra ◽  
M K Mitra ◽  
N N Gupta

The results of using high doses of intravenous frusemide in the management of 28 patients suffering from chronic renal failure are presented. The results are compared with those obtained from 14 patients also suffering from chronic renal failure, who received identical ‘conservative management’ but were not treated with diuretics. Large doses of intravenous frusemide produced a satisfactory diuretic response in a higher percentage of treated patients (71%) compared with controls (36%). It was also observed that in the treated group of patients a significant diuretic response could be obtained in patients with a creatinine clearance below 4 ml per minute. The study also demonstrated that in the group of patients receiving frusemide the response was better in those who were given a progressive-dose regime; 88% of patients improved with this regime compared with 68% of patients who were treated with a fixed dose of frusemide. Transient deafness with tinnitus and vertigo were the only side-effects observed. However these effects were only seen in patients who received 1000 mg or more frusemide in one day, administered over a period of one to two hours. It is concluded that all patients suffering from chronic renal failure should be given a trial of large doses of intravenous frusemide therapy, along with other conventional measures, particularly where facilities for dialysis are not immediately available.


2016 ◽  
Vol 17 (4) ◽  
pp. 753-762 ◽  
Author(s):  
Fernanda Washington MENDONÇA-LIMA ◽  
◽  
Roberto Borges dos SANTOS ◽  
Luciano Cezar SANTOS ◽  
Farouk ZACHARIAS ◽  
...  

SUMMARY The present study assessed the in vivo anthelmintic activity of the C. mollis leaf decoction extract when administered orally to naturally infected goats with gastrointestinal nematodes. To this, animals were randomized into three groups:non-treated, control (treated with doramectin 1mL/50 kg b.w.) and C. mollis extract treated groups (2.5mg/kg b.w.). Blood and faecal samples were collected from each animal at day 0, and 30th day posttreatment to monitor immunological and parasitological parameters. A significant faecal egg reduction (61.1%) and an increase in IgA and eosinophils levels were observed in the C. mollis extract treated group, in comparison to the untreated and doramectin groups. Considering that gastrointestinal nematode infections in small ruminants are serious problems in the world, causing economic losses worldwide, associated to high anthelmintic cost, resistance to available anthelmintics and residue problems in meat and milk for human consumption, the plant extract use is an area of interest to search new anthelmintic agents. Thus, Cratyliamollis Mart. Ex Benth, an important medicinal plant from Brazilian Northeast semiarid region, is used to treat different types of diseases, and as forage supplementation. Therefore, the data indicated the potential anthelmintic activity of C. mollis extract; further research is thereby warranted to assess its value for therapeutic purposes.


2021 ◽  
Vol 15 (1) ◽  
pp. 66-74
Author(s):  
Sara Lucena Amorim ◽  
Alex Cicinato Paulino de Oliveira ◽  
Renato Mesquita Peixoto ◽  
Lucas da Silva Bastos ◽  
Wilson Wouflan Silva ◽  
...  

The purpose of this study was to evaluate the anthelmintic effect of the root and stem of Uncaria guianensis on eggs and larvae of gastrointestinal nematodes from naturally infected sheep. The extract of the root of Uncaria guianensis was tested at concentrations of 0.57mg / mL and 1.14mg / mL and the extract of the stem of Uncaria guianensis at concentrations of 1.25mg / mL and 2.5mg / mL. The animals were divided in groups of five animals each, where four groups received the plant extract and a dose / concentration, one group received the anti-helminthic closantel and another group received only distilled water, totaling six treated groups. Ten mL were applied orally on days treatment, in a single dose for the groups treated with the extract, the closantel group received the dose recommended by the manufacturer and the negative group received 10 mL of distilled water. Stool samples were collected weekly for parasitological analysis and blood for hematocrit. The results of the OPG were analyzed after log transformation (x + 1) and submitted to one-way analysis of variance (ANOVA) and Tukey’s test at 5% of probability. Third stage L3 larvae were recovered from co-culture and subjected to the 5% tukey test. The results showed a reduction in the number of eggs per gram of feces, in the group treated with Uncaria guianensis root at a concentration of 1.14mg / mL and in the chemically treated group, where they obtained a statistically significant reduction (p <5%), when compared to the other treated groups, presenting 69% and 66% respectively in the reduction percentage. Regarding the number of third-stage larvae of gastrointestinal nematodes recovered from sheep, after treatment they observed that the groups treated with closantel, Uncaria guianensis root at a concentration of 1.14mg / mL and a stem of Uncaria guianensis at a concentration of 1.25mg / mL were statistically different (p <5%) from the other treatments, with 68%, 68% and 86% respectively reduction in the number of larvae. As for the hematocrit, the results remained within the reference standards for the Amazon Biome. Thus, we conclude that Uncaria guianensis has ovicidal and larvicidal activity on gastrointestinal nematodes in sheep.


2024 ◽  
Vol 84 ◽  
Author(s):  
E. Madrigal-Bujaidar ◽  
P. Gómez-González ◽  
S. Camacho-Cantera ◽  
J. A. Morales-González ◽  
E. Madrigal-Santillán ◽  
...  

Abstract The present research was made to determine the micronuclei and cytotoxic capacity of the antidepressant venlafaxine in an in vivo acute and subchronic assays in mouse. In the first study, we administered once 5, 50, and 250 mg/kg of the drug, and included a negative and a daunorubicin treated group. Observations were daily made during four days. The subchronic assay lasted 5 weeks with daily administration of venlafaxine (1, 5, and 10 mg/kg) plus a negative and an imipramine administered groups. Observations were made each week. In the first assay results showed no micronucleated polychromatic erythrocytes (MNPE) increase, except with the high dose at 72 h. The strongest cytotoxic effect was found with 250 mg/kg at 72 h (a 51% cytotoxic effect in comparison with the mean control level). In the subchronic assay no MNPE increase was found; however, with the highest dose a significant increase of micronucleated normochromatic erythrocytes was observed in the last three weeks (a mean of 51% respect to the mean control value). A cytotoxic effect with the two high doses in the last two weeks was observed (a polychromatic erythrocyte mean decrease of 52% respect to the mean control value). Results suggest caution with venlafaxine.


1995 ◽  
Vol 29 (4) ◽  
pp. 384-386 ◽  
Author(s):  
Kelley C Trent ◽  
Lesley Myers ◽  
Jan Moreb

Objective: To report a lomustine overdose in a patient with anaplastic astrocytoma. Case Summary: A 28-year-old woman with anaplastic astrocytoma was treated with partial resection and radiation therapy followed by a lomustine-containing regimen. The patient took lomustine 1400 mg po over a week, her regular dose being 200 mg on day 1 of the regimen. Pancytopenia developed within a week after the last dose of lomustine and the patient was admitted to the bone marrow transplant unit for supportive care. About 3 weeks later, the patient gradually developed a multiorgan dysfunction, including liver, brain, and lungs without evidence of infection or tumor progression, and died on day 45 of hospitalization. Discussion: This is the third reported case of lomustine overdose that resulted from supplying the patient with more tablets than needed for 1 dose. Although late hematopoietic recovery may be possible after such a high dose of lomustine, other organ toxicities might be detrimental. Conclusions: Physicians and pharmacists should avoid supplying more tablets than needed for 1 lomustine dose. High doses of lomustine may cause irreversible multiorgan toxicities.


VASA ◽  
2010 ◽  
Vol 39 (4) ◽  
pp. 344-348 ◽  
Author(s):  
Jandus ◽  
Bianda ◽  
Alerci ◽  
Gallino ◽  
Marone

A 55-year-old woman was referred because of diffuse pruritic erythematous lesions and an ischemic process of the third finger of her right hand. She was known to have anaemia secondary to hypermenorrhea. She presented six months before admission with a cutaneous infiltration on the left cubital cavity after a paravenous leakage of intravenous iron substitution. She then reported a progressive pruritic erythematous swelling of her left arm and lower extremities and trunk. Skin biopsy of a lesion on the right leg revealed a fibrillar, small-vessel vasculitis containing many eosinophils.Two months later she reported Raynaud symptoms in both hands, with a persistent violaceous coloration of the skin and cold sensation of her third digit of the right hand. A round 1.5 cm well-delimited swelling on the medial site of the left elbow was noted. The third digit of her right hand was cold and of violet colour. Eosinophilia (19 % of total leucocytes) was present. Doppler-duplex arterial examination of the upper extremities showed an occlusion of the cubital artery down to the palmar arcade on the right arm. Selective angiography of the right subclavian and brachial arteries showed diffuse alteration of the blood flow in the cubital artery and hand, with fine collateral circulation in the carpal region. Neither secondary causes of hypereosinophilia nor a myeloproliferative process was found. Considering the skin biopsy results and having excluded other causes of eosinophilia, we assumed the diagnosis of an eosinophilic vasculitis. Treatment with tacrolimus and high dose steroids was started, the latter tapered within 12 months and then stopped, but a dramatic flare-up of the vasculitis with Raynaud phenomenon occurred. A new immunosupressive approach with steroids and methotrexate was then introduced. This case of aggressive eosinophilic vasculitis is difficult to classify into the usual forms of vasculitis and constitutes a therapeutic challenge given the resistance to current immunosuppressive regimens.


1958 ◽  
Vol 02 (01/02) ◽  
pp. 111-124 ◽  
Author(s):  
E Deutsch ◽  
K Martiny

Summary1. Normal platelets are necessary for induction of normal clot retraction.2. Serotonin does not induce retraction in human platelet-free plasma-clots or enhance clot firmness as measured in the coagulogram.3. Serotonin does not improve clot retraction or firmness in plasma clots with sub-optimal platelet counts.4. Methylserotonin inhibits clot retraction of platelet-rich plasma to a certain extent in moderate doses, whereas, high doses are ineffective. BOL 148 has a similar, but less significant action. There is a possibility that these effects are specific antiserotonin-effects.5. LSD 25 was ineffective in all concentrations used.6. Largactil and reserpin inhibit retraction in high doses. There seems to be a non specific effect caused by the high dose.7. Reserpine does not release a retraction-inducing agent from the platelets, which could be detected in the centrifuged platelet-free plasma used for the incubation.8. Serotonin does not replace the retraction-cofactor of Hartert, or the dialyzable factor of Lüscher in synthetic clotting substrates.9. Serotonin is of no essential value in inducing normal retraction of human plasma clots.


Author(s):  
Najat F. Mohammed Salih ◽  
Gazwa D. Al-Nakeeb

This study aimed to compare the histological changes in the neonatal kidney after their mothers exposed to different doses of silver nanoparticles colloidal solution (AgNPs) during the three stages of pregnancy. Pregnant Swiss albino mice (n=60) were randomly divided into three treated groups. They were intraperitoneally injected with AgNPs for 7 days during each stage of the gestational period. The newborn mice were sacrificed immediately after the birth, and the kidneys were being collected for histopathological analysis. The results showed that the AgNPs caused histological changes in the neonatal kidneys; vacuolation of some renal vesicles and cortical tubules, cystic tubular dilation, glomerular tuft shrinkage, and focal tubular necrosis in the first week-dose exposed pregnant. Disintegrating of immature glomeruli, distention of Bowman’s space of mature glomeruli, tubular necrosis, loss of renal parenchyma, medullar tubules containing hyaline casts, and subcapsular haemorrhage in the second week-dose exposed pregnant. Massive hypercellularity in the deeper part of the renal cortex, cortical and medullary tubules dilation, atrophy of subcapsular immature tubules, cortical cyst formation, glomerular tuft necrosis, dilation of Bowman’s space with evidence of crescent formation, and medullar portion replaced by scant loose connective tissue containing few numbers of tubules the third week-dose exposed pregnant. The results showed that the AgNPs has more negative effects on the kidney development at the third week-high dose and comparing the histological changes in the neonatal kidney were appeared in a time-depended manner and in a dosedepended manner. More researches must be carried out to obtain better understanding of AgNPs toxicity on fetal development and its ability as a teratogenic agent to induce external and internal abnormalities in the fetus.


Author(s):  
Mona Aslani ◽  
Arman Ahmadzadeh ◽  
Zahra Aghazadeh ◽  
Majid Zaki-Dizaji ◽  
Laleh Sharifi ◽  
...  

Background: : Based on the encouraging results of phase III clinical trial of β-D-mannuronic acid (M2000) (as a new anti-inflammatory drug) in patients with RA, in this study, we aimed to evaluate the effects of this drug on the expression of chemokines and their receptors in PBMCs of RA patients. Methods:: PBMCs of RA patients and healthy controls were separated and the patients' cells were treated with low, moderate and high doses (5, 25 and 50 μg/mL) of M2000 and optimum dose (1 μg/mL) of diclofenac, as a control in RPMI-1640 medium. Real-time PCR was used for evaluating the mRNA expression of CXCR3, CXCR4, CCR2, CCR5 and CCL2/MCP-1. Cell surface expression of CCR2 was investigated using flow cytometry. Results:: CCR5 mRNA expression reduced significantly, after treatment of the patients' cells with all three doses of M2000 and optimum dose of diclofenac. CXCR3 mRNA expression down-regulated significantly followed by treatment of these cells with moderate and high doses of M2000 and optimum dose of diclofenac. CXCR4 mRNA expression declined significantly after treatment of these cells with moderate and high doses of M2000. CCL2 mRNA expression significantly reduced only followed by treatment of these cells with high dose of M2000, whereas, mRNA and cell surface expressions of CCR2 diminished significantly followed by treatment of these cells with high dose of M2000 and optimum dose of diclofenac. Conclusion:: According to our results, M2000 through the down-regulation of chemokines and their receptors may restrict the infiltration of immune cells into the synovium.


Sign in / Sign up

Export Citation Format

Share Document